The acetylcholine receptor-operated K + (K ACh ) channel may be a novel target for atrial-specific antiarrhythmic therapy. Recently it has been demonstrated that tertiapin, a selective blocker of K ACh channel, suppressed aconitine-induced atrial fibrillation (AF) in dogs. However, precise mechanism by which the K ACh channel blocker inhibits the aconitine-induced AF remains unknown. This study was undertaken to determine the role of 
Introduction
Aconitine, a poisonous alkaloid known as an arrhythmogenic compound, activates Na + channels with inactivation slowing, and produces intracellular Na + accumulation in cardiac cells (1) (2) (3) . The alkaloid has long been used to produce experimental atrial fibrillation (AF)
probably due to induction of abnormal automaticity.
Recently much attention has been focused on the acetylcholine receptor-operated K + (K ACh ) channel as a novel target of pharmacotherapy for atrial fibrillation because activation of K ACh channel may play an important role in the induction of parasympathetic-type atrial fibrillation occurring at night, at rest and/or after consuming meals or alcohol (4) . Several atria-selective antiarrhythmic drugs blocking K ACh channels, such as NIP-151 and NTC-801, have been developed (5, 6) . It has been demonstrated that not only these atria-selective antiarrhythmic drugs but also tertiapine, a bee venom peptide specifically inhibiting K ACh current (I K.ACh ) without affecting other membrane currents (7) (8) (9) , can effectively terminate aconitine-induced AF in dogs (6, 10) . However, precise mechanism by which these K ACh channel blockers inhibit aconitine-induced AF model remains unknown. Therefore, this study was undertaken to explore the mechanism by which the specific K ACh channel blocker tertiapine inhibits the aconitine-induced AF.
solution [modified Kraft-Brühe (KB) solution]. Atrial tissue was minced in the modified KB solution, and the pieces were gently agitated to dissociate cells. The cell suspension was stored at 4°C until use.
Whole-cell patch clamp experiments
The whole-cell patch-clamp techniques were used for the recordings of membrane currents and action potentials from single atrial cells. A patch-clamp amplifier (CEZ-2400, Nihon Kohden, Tokyo, Japan) was used for current-and voltage-clamp experiments. Pipette electrodes (resistance 4-6 MΩ) were made by using a Narishige pipette puller (PB-7, Narishige Scientific Instruments Laboratory, Tokyo, Japan). After the gigaohm seal between tip and cell membrane was formed, we ruptured the patch membrane to form the whole-cell patch clamp configuration. In the current-clamp mode, action potentials were evoked by stimulation of the atrial cell at an interval of 5 s. In the voltage-clamp mode, a ramp-pulse protocol was used to record the quasi-steady-state membrane current at an interval of 20 s.
The membrane potential was held at −40 mV and depolarized to +50 mV in 150 ms. It was then repolarized or hyperpolarized to −100 mV in 250 ms, during which time the change in the membrane current was automatically plotted against the membrane potential.
The experiments were performed at 36°C. The current signals were filtered at 10 kHz and digitalized at 1 or 2 kHz by using an A/D converter (Digidata 1322A, Axon Instruments Inc., Union City, CA, USA). All data were stored on a computer for later analysis with pCLAMP9 software (Axon Instruments).
Two dimensional electrical mapping
The 64-channel multi-electrode dish system (MED64, Alpha MED Scientific Inc., Osaka, Japan) was used for two dimensional electrical mapping. The system was equipped with MED-P545A probes with 450 µm interpolar distance of electrodes, a chamber with depth of 10 mm and 64 planar microelectrodes in an 8 × 8 array for determination of the propagation patterns in atrial preparations. Atrial appendages were obtained from anesthetized guinea pigs and washed with Krebs-Henseleit solution. The experiments were performed at 36°C. Atrial preparations were superfused with oxygenated Krebs-Henseleit solution and electrically stimulated at 0.5 Hz. Data obtained with this system were analyzed using the software (MED64 conductor for evaluation) and custom-made macros in Excel (Microsoft, Redmont, WA, U.S.A.). Experimental groups were composed of preparations exposed to 3 µM aconitine alone (n = 5), 3 µM aconitine followed by addition of 30 nM tertiapine (n = 6) and 3 µM aconitine followed by addition of 10 µM pilsicainide (n = 5). Conduction velocity was calculated from electrical mapping data at several time points in each experiment.
Solutions
The compositions of the buffers used in the experiments are as follows: 1) Normal 
Results

In vivo experiments evaluating drug effects on aconitine-induced AF
Topical application of aconitine on the right atrium induced AF in anesthetized guinea pigs ( Figure 1B and 1E ). After induction of AF tertiapin (100 µg / kg) was intravenously administered to the guinea pig via femoral vein. Injection of tertiapin immediately converted the aconitine-induced AF to sinus rhythm, as shown in Figure 1C . Administration of pilsicainide (3 mg / kg), a class Ic antiarrhythmic drug, also terminated the aconitine-induced AF ( Figure 1F ). Success rates of AF termination with tertiapin (100 µg / kg) and pilsicainide (3 mg / kg) were 6/7 and 4/8, respectively. It was reported that pilsicainide showed efficacy in canine arrhythmia models at the effective serum concentrations ranging from 0.25 µM to ms, and addition of 30 nM tertiapin increased the APD 90 to 106.5 ± 9.6 ms (n=7, p<0.01) ( Figure 2D ). In order to compare the effect of aconitine with that of carbachol, effects of tertiapin on the carbachol-induced action potential changes were examined. Carbachl at a concentration of 3 nM shortened APD in atrial cells, which was readily antagonized by 30 nM tertiapin ( Figure 2C ). APD 90 was changed from 86.3 ± 11.2 ms to 63.3 ± 10.9 ms after 3 nM carbacol and it was increased to 96.4 ± 19.6 ms after addition of 30 nM tertiapin (n=5) ( Figure 2D ). Thus, both carbachol and tertiapine shortened atrial action potential and the action potential shortening was antagonized by the K ACh channel blocker tertiapin.
Tertiapin-sensitive current induced by aconitine and carbachol
The quasi-steady-state membrane current was recorded in the voltage-clamp mode using a ramp-pulse protocol. Addition of 30 nM tertiapin very slightly decreased the steady-state outward current ( Figure 3A ). Aconitine at a concentration of 3 µM slightly enhanced the steady-state outward current, and addition of 30 nM tertiapin reduced the steady-state membrane current enhanced by aconitine, as shown in Figure 3B . Carbachol at a concentration of 3 nM definitely increased the steady-state outward current, which was antagonized by 30 nM tertiapin ( Figure 3C ).
We measured the tertiapin-sensitive current at 0 mV. Since tertiapin is known to selectively inhibit I K.ACh without any appreciable effect on other major ionic currents (I Kr , I Ks , I to , I K1 , I KATP , I Na , and I CaL )(9), the tertiapin-sensitive current would be designated as I K.ACh .
Tertiapin-sensitive current at 0 mV in the absence of any drug was very small ( Figure 3D ).
The tertiapin-sensitive current at 0 mV in the presence of 3 µM aconitine (0.65 ± 0.10 pA/pF, n=10) was slightly and insignificantly larger than that in the absence of any drug (0.29 ± 0.13 pA/pF, n=13). Carbachol (3 nM) produced a significantly greater increase of tertiapin-sensitive current (2.43 ± 0.77 pA/pF, n=5) than that induced by aconitine ( Figure   3D ).
Changes of membrane potentials after longer exposure to aconitine in atrial cells
Membrane potentials of isolated atrial cells were measured in the current-clamp mode.
When atrial cells were exposed to 3 µM aconitine for a longer time, abnormal automaticity appeared and then 30 nM tertiapin was added to the external solution. Immediately after introduction of 3 µM aconitine the APD was shortened, and a few minutes later abnormal automaticity appeared, as shown in Figure 4A . After induction of abnormal automaticity 30 nM tertiapin was added to the external solution and tertiapin markedly decreased the resting membrane potentials ( Figure 4A ). Figure 4B summarizes the changes of the resting membrane potential at the times when the abnormal automaticity was induced by aconitine, and when tertiapin was added to the external solution. Aconitine per se slightly decreased the resting membrane potentials from -78.6 ± 1.0 mV to -70.9 ± 5.3 mV, and addition of tertiapin further decreased it to -40.2 ± 3.6 mV (p<0.01, n = 7).
In vitro two dimensional electrical mapping in isolated atrial preparations
We conducted the in vitro two dimensional electrical mapping experiments using atrial preparations of guinea pigs with MED64 multi-electrode array system. Electrical stimulation and recording of field potentials in isolated atrial tissues were conducted with MED64 system. Atrial preparations were placed directly on a grid of 64 planar microelectrodes, which serve a dual purpose of stimulus-delivery and signal recording. The time of signal peaks were recorded and plotted. In the mapping experiments, one color represented the time of signal peaks within 2 ms.
Firstly we started the electrical stimulation from some 2 adjacent electrodes in the atrial tissue placed on the probe. When we applied 3 µM aconitine to the preparation, the ectopic firing was induced. At 15 min after introduction of aconitine, we added 30 nM tertiapin or 10 µM pilsicainide to the aconitine-containing solution. Aconitine induced ectopic firing with slowed conduction, as observed in the two dimensional electrical mapping of atrial preparations ( Figure 5D , E, F). Addition of tertiapin further decreased the conduction velocity in preparations with combined treatment (Figure 5H ), compared to the preparation treated with aconitine alone ( Figure 5G ). In a similar fashion addition of 10 µM pilsicainide further decreased the conduction velocity ( Figure 5I ). These drugs sometimes produced a collision of excitation waves. Thus either tertiapin or pilsicainide can decrease the conduction velocity, thereby producing conduction block. 
Discussion
It is assumed that paroxysmal AF occurring at night, at rest, and/or after consuming meals or alcohol is caused by the activation of K ACh channels (4). It is acknowledged that vagal nerve stimulation (VNS) shortens the atrial effective refractory period (ERP) and increases the heterogeneity via the activation of I K.ACh , which can facilitate the onset of AF.
Recently it has been reported that NTC-801, a selective K ACh channel blocker, effectively terminated VNS-induced AF in dogs (6). It is not surprising that the K ACh channel blocker readily inhibited the VNS-induced AF. However, the K ACh channel blocker could also inhibit aconitine-induced AF in dogs (6) . The effectiveness of the K ACh channel blocker against aconitine-induced AF cannot be readily explained.
Aconitine has long been known as an arrhythmogenic compound. Aconitine is assumed to inhibit voltage-dependent Na + channel inactivation and causes intracellular Na + accumulation, resulting in intracellular Ca 2+ accumulation and abnormal automaticity such as delayed afterdepolarizations and triggered activity (14) . Ectopic activity resulting from abnormal automaticity may trigger atrial fibrillation by reentrant mechanism. It has been suggested that aconitine may bind to site 2 receptor Na + channel and local anesthetics may noncompetitively inhibit the site 2 binding of plant alkaloid toxin (15) . Aconitine was reported to induce early afterdepolarization, delayed afterdepolarization and triggered activity in isolated cardiomyocytes and cardiac tissues (16, 17) . Consistent with the reports, we could observe abnormal automaticity in guinea-pig atrial cells after application of aconitine. In order to test this hypothesis we conducted electrophysiological experiments.
Aconitine slightly shortened action potential duration (APD) at its early stage, and addition of tertiapin reversed the APD shortening ( Figure 2) . We could observe a tertiapin-sensitive current after application of aconitine, which was slightly larger than that observed without aconitine treatment (Figure 3 ), although the muscarinic agonist carbachol produced more definite APD shortening and larger tertiapin-sensitive current. Aconitine might activate K ACh current by intracellular Na + accumulation. When atrial cells were exposed to aconitine for a longer time, spontaneous activity appeared (Figure 4 ). With addition of tertiapin, the resting membrane potential was marked reduced. Some inward current, resulting from Na + current with slowed inactivation and intracellular Na + /Ca 2+ accumulation, might play an important role in the marked depolarization of the resting membrane. Activated K ACh channels might contribute to keeping the resting membrane potential toward more hyperpolarizing direction.
With K ACh channel blockade marked membrane depolarization due to increased inward current might become overt.
We conducted the in vitro two dimensional electrical mapping experiments using atrial preparations of guinea pigs. Aconitine induced ectopic firing in atrial preparations and gradually produced conduction slowing. Addition of tertiapin or pilsicainide further decreased the conduction velocity in the preparations pretreated with aconitine, which was more marked compared to that observed in the preparation treated with aconitine alone. Either tertiapin or pilsicainide might decrease the conduction velocity, thereby producing conduction block.
Inhibition of I K.ACh and reduction of the resting membrane potential by tertiapin in the presence of aconitine might play an important role in conduction slowing and resultant termination of AF. It is well known that the availability of sodium current, I Na , decreases as the resting membrane potential depolarizes, resulting in a decrease of conduction velocity in cardiac tissues (22-24). Therefore, tertiapin might produce conduction block in reentrant pathway and/or propagation pathway from ectopic focus with abnormal automaticicty.
Pilsicainide might similarly terminate the aconitine-inducced AF by producing conduction block. In this context it has been recently reported that pilsicainide decreased the conduction velocity in the left atrium as well as pulmonary vein of guinea pigs (25).
It is well known that rapid atrial pacing produces electrical remodeling in the atrium, an arrhythmogenic substrate, and easily induces AF with a burst of atrial stimulation (26, 27) .
It is acknowledged that the densities of several membrane currents such as the L-type Ca . Effects on aconitine alone, addition of tertiapin and pilsicainide on conduction velocity calculated from mapping data. After introduction of 3 µM aconitine mapping data were obtained at 15 min and 20 min in aconitine alone group . In tertiapin group and pilsicainide group, the mappings data were obtained at 15 min after application of 3 µM aconitine (just prior to addition of tertiapin or pilsicainide) and at 5 min after addition of tertiapin or pilsicainide to the aconitinecontaining solution. Values are expressed as mean ± S.E of 5 preparations for aconitine alone group, 6 preparations for tertiapin group and 5 preparations for pilsicainide group. Statistical significance was evaluated by ANOVA.
